SATELLITE SYMPOSIA: PFIZER
Improve outcomes for HR+/HER2- breast cancer patients: a multidisciplinary case-based discussion
Welcome and Introduction: Dr Alistair Ring, Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust
A patient with locally advanced breast cancer: what is the role of Ibrance®q(palbociclib)?
Mr. Henry Cain, Oncoplastic Breast Surgeon, The Newcastle upon Tyne Hospitals NHS Foundation Trust
A patient with metastatic breast cancer, who progressed on adjuvant endocrine treatment: where Ibrance®q(palbociclib) is now an option
Professor Christopher Poole, Consultant Medical Oncologist, University Hospitals Coventry and Warwickshire NHS Trust
A patient with high burden metastatic breast cancer including visceral metastasis: what factors influence the choice of treatment?
Dr. Alistair Ring & Ms. Claire Ryan, Macmillan Nurse Consultant Metastatic Breast Cancer, Maidstone and Tunbridge Wells NHS Trust